Streptomyces chrestomyceticus

Streptomyces chrestomyceticus is a bacterium species from the genus of Streptomyces.[1] Streptomyces chrestomyceticus produces lycopene, pyrrolostatin, paromomycin, aminocidin, aminosidin, neomycin E and neomycin F.[2][3][4][5][6][7][8]

Streptomyces chrestomyceticus
Scientific classification Edit this classification
Domain: Bacteria
Phylum: Actinomycetota
Class: Actinomycetia
Order: Streptomycetales
Family: Streptomycetaceae
Genus: Streptomyces
Species:
S. chrestomyceticus
Binomial name
Streptomyces chrestomyceticus
Canevazzi and Scotti 1959[1]
Type strain
AS 4.1657, ATCC 14947, BCRC 12173, CBS 745.72, CCRC 12173, CGMCC 4.1657, CMI 79589, DSM 40545, DSM 40820, IFO 13444, IMRU 3835, ISP 5545, JCM 4735, KCC S-0735, KCCS-0735, MTCC 6922, NBRC 13444, NCAIM B.01478, NCIB 8995, NCIMB 10999, NCIMB 8995, NRRL B-3293, NRRL B-3310, NRRL B-3672, NRRL-ISP 5545, RIA 1405, Waksman 3835

Further reading

edit
  • KATO, SHINICHIRO; SHINDO, KAZUTOSHI; KAWAI, HIROYUKI; ODAGAWA, ATSUO; MATSUOKA, MICHIKO; MOCHIZUKI, JUNICHIRO (1993). "Pyrrolostatin, a novel lipid peroxidation inhibitor from Streptomyces chrestomyceticus. Taxonomy, fermentation, isolation, structure elucidation and biological properties". The Journal of Antibiotics. 46 (6): 892–899. doi:10.7164/antibiotics.46.892. PMID 8344870.
  • Vandamme, Erick J., ed. (1989). Biotechnology of Vitamins, Pigments and Growth Factors. Dordrecht: Springer Netherlands. ISBN 94-009-1111-4.
  • Perlman, D.; H.J. Peppler, eds. (1979). Microbial Technology Microbial Processes (2nd ed.). Oxford: Elsevier Science. ISBN 0-323-16156-1.
  • ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4. {{cite book}}: |last1= has generic name (help)
  • Janssens, Pieter G.; Hugo Vanden Bossche; Denis Thienpont, eds. (1985). Chemotherapy of Gastrointestinal Helminths. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-69527-2.
  • Waites, Michael J.; et al. (2009). Industrial microbiology an introduction. Osney Mead, Oxford: Blackwell Science. ISBN 978-1-4443-1158-7.
  • Kumar, Awanish (2013). Leishmania and leishmaniasis. New York, NY: Springer New York. ISBN 978-1-4614-8869-9.
  • Petersen, Frank; Amstutz, René, eds. (2008). Natural compounds as drugs (online ed.). Basel: Birkhäuser. ISBN 978-3-7643-8117-2.
  • Gordon, Michael; Jan Pokorny; Nedyalka Yanishlieva, eds. (2001). Antioxidants in food Practical applications. Cambridge: Woodhead Pub. ISBN 1-85573-616-0.
  • Buckingham, J., ed. (1996). Second supplement (1st ed.). London: Chapman & Hall. ISBN 0-412-60420-5.

See also

edit

References

edit
  1. ^ a b LPSN bacterio.net
  2. ^ Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
  3. ^ Kato, S; Shindo, K; Kawai, H; Odagawa, A; Matsuoka, M; Mochizuki, J (June 1993). "Pyrrolostatin, a novel lipid peroxidation inhibitor from Streptomyces chrestomyceticus. Taxonomy, fermentation, isolation, structure elucidation and biological properties". The Journal of Antibiotics. 46 (6): 892–9. doi:10.7164/antibiotics.46.892. PMID 8344870.
  4. ^ Theodor, Hellbrügge (1966). Pädiatrische Diagnostik/Pädiatrische Therapie. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 3-642-94949-5.
  5. ^ Miljković, Momčilo (2009). Carbohydrates synthesis, mechanisms, and stereoelectronic effects. New York: Springer. ISBN 978-0-387-92265-2.
  6. ^ Pelletier, Georgia; S. William, eds. (1999). Alkaloids chemical and biological perspectives. Amsterdam: Pergamon. ISBN 0-08-052702-7.
  7. ^ A. Gossauer (2003). Kirby, G.W.; W. Herz; H. Falk (eds.). Fortschritte der Chemie organischer Naturstoffe [Progress in the Chemistry of Organic Natural Products]. Vienna: Springer Vienna. ISBN 3-7091-6029-4.
  8. ^ Prakash, Dhan; Sharma, Girish, eds. (2014). Phytochemicals of nutraceutical importance (Online-Ausg. ed.). Wallingford: CAB International. ISBN 978-1-78064-363-2.
edit